Pharmacometabolomics


The study of metabolites produced by the body and their quantification and analysis is known as metabolomics. Pharmacometabolomics is a branch of this discipline. It describes the precise measurement of metabolites in a person's physiological fluids, imagines or assesses how pharmaceutical chemicals are metabolised, and enhances comprehension of the pharmacokinetic profile of a medicine. Contrarily, pharmacometabolomics can be used to assess metabolite levels after a pharmacological substance has been administered in order to track the compound's effects on specific metabolic pathways. This gives a thorough picture of how drugs affect metabolism and the pathways that may play a role in the variability of treatment response. Additionally, the metabolic profile of a person at baseline reveals variation within a population health  and offers information about how people respond to treatment


    Related Conference of Pharmacometabolomics

    April 16-17, 2025

    9th International Conference on Internal Medicine

    Berlin, Germany
    May 12-13, 2025

    19th International Conference on Obesity Medicine

    Toronto, Canada
    June 24-25, 2025

    3rd Global Summit on HIV-AIDS and STDs

    Chicago, USA
    July 21-22, 2025

    24th International Conference on Genomics and Molecular Biology

    Aix-en-Provence, France
    July 21-22, 2025

    11th World Congress on Anesthesia and Critical Care

    Aix-en-Provence, France
    August 07-08, 2025

    12th World Summit on Epilepsy and Bipolar Disorders

    Paris, France
    November 03-04, 2025

    5th World Medicine Congress

    Rome, Italy

    Pharmacometabolomics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in